Access our press/media kit

Videos

  • “Clinical Trials: the patient in academic studies”

  • GDPR @ EORTC

    GDPR at EORTC

  • Tailoring medicine to patient needs - Video illustration

    Tailoring medicine to patient needs

  • EORTC: The future of cancer therapy #WeAreEORTC

    EORTC: The future of cancer therapy #WeAreEORTC

Press Releases

  • PRESS RELEASE: Better treatment for better heath: lifting the veil on treatment optimisation

    News,Press release

    PRESS RELEASE: Better treatment for better health: lifting the veil on treatment optimisation

  • Melanoma

    Melanoma Group,News,Press release

    PRESS RELEASE: European Organisation for Research and Treatment of Cancer (EORTC) and Pierre Fabre Partner to Address Treatment Gap for Stage 2 Melanoma Patients

  • Breast cancer study - Ameera-study_EORTC-Sanofi-BIG-AFT

    Breast Cancer Group,News,Press release

    PRESS RELEASE: Sanofi partnering with leading academic cooperative groups to study amcenestrant in the adjuvant setting for patients with estrogen receptor positive breast cancer

  • HRH Princess Dina Mired - ECRF & EORTC Honorary President

    News,Press release

    PRESS RELEASE: HSH Prince Albert II cedes Honorary Presidency of the EORTC Research Fund to HRH Princess Dina Mired

News

Filter on topic
  • PRESS RELEASE: Better treatment for better heath: lifting the veil on treatment optimisation

    News,Press release

    PRESS RELEASE: Better treatment for better health: lifting the veil on treatment optimisation

  • News

    Long-term follow-up of chemoradiotherapy treatment in glioma patients shows significantly increased survival

  • News

    Treatment with decitabine resulted in a similar survival and fewer adverse events compared with conventional chemotherapy in older patients with acute myeloid leukemia

  • Soft Tissue

    Soft tissue & bone

    Quality assurance of radiotherapy in STRASS trial shows importance of its inclusion in trial development

  • Melanoma

    Melanoma Group,News

    Pierre Fabre and EORTC open a large Phase III clinical study in the adjuvant setting of stage IIB-C melanoma

  • News,SPECTA

    EORTC and Alliance Healthcare’s continued partnership in support of SPECTA clinical research infrastructure

  • Radiotherapy Quality Assurance Manager illustration

    News

    Results of radiotherapy quality assurance in the PEACE-1 trial show high adherence to protocol

  • Precision Medicine

    News

    EORTC presents new precision medicine research results at AACR 2022

  • EMA - EORTC Workshop

    News

    Joining forces to optimise cancer treatments in clinical practice: EMA & EORTC launch Cancer Medicines Forum with academia

  • Lung

    Lung Cancer Group,News

    MSD’s KEYTRUDA® (pembrolizumab) Significantly Improved Disease-Free Survival (DFS) Versus Placebo as Adjuvant Therapy in Patients With Stage IB-IIIA Non-Small Cell Lung Cancer (NSCLC) Regardless of PD-L1 Expression